Clinical Trial Update: Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing dapagliflozin, lobeglitazone, and their combination in type 2 diabetes, focusing on efficacy and safety with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Lobeglitazone (lobeglitazone)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes Type 2 | Phase 4 | Status: UNKNOWN